CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −2,400 | $72.07 | $173K | 734,519 |
| 2025-10-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −700 | $73.24 | $51K | 733,819 |
| 2025-10-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −100 | $74.67 | $7K | 733,719 |
| 2025-10-02 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 96,569 |
| 2025-10-01 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-10-01 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −11,705 | $75.11 | $879K | 742,014 |
| 2025-10-01 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −8,295 | $75.69 | $628K | 733,719 |
| 2025-10-01 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 116,569 |
| 2025-10-01 | Connaughton Bernadette Director | Sale 10b5-1 | −1,500 | $75.09 | $113K | 45,452 |
| 2025-10-01 | Connaughton Bernadette Director | Sale 10b5-1 | −500 | $75.70 | $38K | 44,952 |
| 2025-09-22 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,913 | $77.83 | $149K | 22,393 |
| 2025-09-22 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −314 | $78.67 | $25K | 22,079 |
| 2025-09-10 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +11,271 | $12.07 | $136K | 43,171 |
| 2025-09-10 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +1,135 | $12.49 | $14K | 44,306 |
| 2025-09-10 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −6,760 | $75.29 | $509K | 37,546 |
| 2025-09-10 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −13,240 | $75.93 | $1.0M | 24,306 |
| 2025-09-10 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise · Option to Purchase Common Stock 10b5-1 | −11,271 | 0 | ||
| 2025-09-10 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise · Option to Purchase Common Stock 10b5-1 | −1,135 | 812 | ||
| 2025-09-04 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-09-04 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −9,900 | $73.54 | $728K | 743,819 |
Page 15 of 26 · 513 trades